Radio-responsive recA promoter significantly increases TNF alpha production in recombinant clostridia after 2 Gy irradiation

S Nuyts*, L Van Mellaert, J Theys, W Landuyt, E Bosmans, J Anne, P Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

23 Downloads (Pure)

Abstract

One of the major problems with gene therapy today is the lack of tumour specificity. The use of anaerobic apathogenic clostridia as a gene transfer system can target anoxic areas within the tumour. These bacteria can be genetically modified to express therapeutic proteins such as TNF alpha locally in the tumour. As shown in our results, ionising irradiation can be used in clostridia to activate genes encoding cytotoxic agents under control of a radiation-inducible promoter. A 44% significant increase (P < 0.05) in TNF secretion was seen 3.5 h after a single dose of 2 Gy. A second dose of 2 Gy was also capable of repeating gene activation and gave a significant increase of TNF alpha production of 42% (P < 0.05). These results provide evidence that spatial and temporal control of gene expression can be achieved using a radio-inducible promoter. Repetitive gene activation was feasible with a second dose of 2 Gy, indicating that fractionated radiotherapy could lead to repeated gene induction resulting in prolonged and enhanced protein expression. Gene targeting by ionising radiation could thus provide a new means of increasing the therapeutic ratio in cancer treatment.

Original languageEnglish
Pages (from-to)1197-1201
Number of pages5
JournalGene Therapy
Volume8
Issue number15
DOIs
Publication statusPublished - Aug 2001

Keywords

  • Clostridium
  • radio-inducible promoter
  • radiotherapy
  • recA
  • TNF alpha
  • TUMOR-NECROSIS-FACTOR
  • CANCER GENE-THERAPY
  • IONIZING-RADIATION
  • DELIVERY-SYSTEM
  • EGR-1 PROMOTER
  • ANAEROBIC-BACTERIA
  • ESCHERICHIA-COLI
  • IN-VITRO
  • ACETOBUTYLICUM
  • ACTIVATION

Cite this